The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical to lay off 14,000 globally; effect on Gurnee facility unclear – Chicago Tribune
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Former Teva officials said to return $50m over fines paid by drugmaker | The Times of Israel
Teva must face government's kickback claims over Copaxone - judge | Reuters
Israeli company Teva Pharmaceutical stocks drop nearly 18% - The Jerusalem Post
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva Pharmaceuticals' massive layoffs | Communist Party of Israel
Israel's Teva Pharmaceuticals Is Recruiting Israeli Academia to Help Produce Its Next Breakthrough Drug | Jewish & Israel News Algemeiner.com
Israel-based Teva Pharmaceutical to lay off 14,000 workers as part of restructuring - St. Louis Jewish Light
Israeli pharmaceutical company Teva receives Chinese approval for new Huntington's treatment - Al-Monitor: The Pulse of the Middle East
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Teva Pharmaceuticals Office Photos | Glassdoor
Teva sheds logistics center for $127M after 2 about-faces | Fierce Pharma
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Jewish Values Investors JLens Target Israeli Company
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
Brussels' Teva probe reveals dark side of patent protections | Financial Times
